FDA Inspection 874754 — Aptalis Pharma Us Inc

Aptalis Pharma Us Inc — FEI 3009801653

The FDA completed an inspection of Aptalis Pharma Us Inc on April 16, 2014 in Hoover, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 16, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Compliance: Devices
Location
Hoover, AL (United States)